title: Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome.
abstract: A patient with an inferior vena cava thrombosis in nephrotic syndrome was treated with heparin, AT-III concentrates and urokinase. After a few days on treatment he showed a complete resolution of the thrombosis. We suggest that this therapeutic combination may be a good approach to the treatment of thrombosis in nephrotic syndrome.
authors: Università Cattolica del Sacro Cuore, Rome, Italy.
authors: S
authors: S
authors: Storti
authors: L
authors: L
authors: Pagano
authors: R
authors: R
authors: Marra
authors: A
authors: A
authors: Grilli
authors: G
authors: G
authors: Falappa
authors: A M
authors: AM
authors: De Gaetano
authors: A M
authors: AM
authors: Ferrante
authors: B
authors: B
authors: Bizzi
mesh_terms: D058186:Acute Kidney Injury / Q000150:complications; D000328:Adult; D000990:Antithrombin III / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications*; D011655:Pulmonary Embolism / Q000139:chemically induced; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D014682:Vena Cava, Inferior
chemical_list: D000990:Antithrombin III; D014568:Urokinase-Type Plasminogen Activator